MicroMOB: Microbial mobility pathways in chronic kidney disease and its role in infection and systemic inflammation. (Q2906625): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: co-financing rate (P837): 85.0 percentage) |
(Changed an Item: Import item from Portugal) |
||||||||||
Property / budget | Property / budget | ||||||||||
| 239,456.05 Euro
| ||||||||||
Property / EU contribution | Property / EU contribution | ||||||||||
| 203,537.64 Euro
| ||||||||||
Property / priority axis | |||||||||||
Property / priority axis: Strengthening research, technological development and innovation (OT1) / rank | |||||||||||
Normal rank | |||||||||||
Property / co-financing rate | |||||||||||
85.0 percent
| |||||||||||
Property / co-financing rate: 85.0 percent / rank | |||||||||||
Normal rank |
Revision as of 01:50, 5 November 2022
Project Q2906625 in Portugal
Language | Label | Description | Also known as |
---|---|---|---|
English | MicroMOB: Microbial mobility pathways in chronic kidney disease and its role in infection and systemic inflammation. |
Project Q2906625 in Portugal |
Statements
203,537.64 Euro
0 references
239,456.05 Euro
0 references
85.0 percent
0 references
1 July 2018
0 references
31 December 2021
0 references
INEB-INSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA
0 references
Q2993187 (Deleted Item)
0 references
Porto
0 references
Identifiers
POCI-01-0145-FEDER-029777
0 references